The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Abstract
Summary: Tissue damage occurs often in the life of mammals and is usually repaired. Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs. They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion. Many of these events involve high‐mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes. HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation. Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines. Activated leukocytes actively secrete HMGB1 in the microenvironment. Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long‐term repair and defense programs. DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is critical for their ability to reach the lymph nodes, to sustain the proliferation of antigen‐specific T cells, to prevent their activation‐dependent apoptosis, and to promote their polarization towards a T‐helper 1 phenotype. These immune responses will also be directed against self‐antigens that DCs process at the time of injury and can lead to autoimmunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, PRR present on or within DC include a group of signaling receptors that stimulate the post uptake reactions (including toll-like receptors, NOD-like receptors, and RIG1-like helicases)52,107.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Similarly, HSPs exposed on or released by tumor cells may act on multiple receptors including CD91, scavenger receptors, TLR2 and TLR4 52.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-citationHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Self-citation
Research works printed but not linked: 1
- Fiuza C, 2002, Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells, Blood, 27, 2652
Cited by
Sorted by citations
Items 501–600 of 600
HMGB1 as a Key Modulator in Nasal Inflammatory Disorders: A Narrative Review
Passàli, D., Bellussi, L. M., Santantonio, M., & Passàli, G. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155392 · Cited by 2
Wen, T., Shi, J., Guo, M., Ma, B., Zhang, C., Zhao, Y., & Xu, F. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.011 · Cited by 2
Zhong, X., Pu, T., Cheng, Y., Li, Y. Y., Wang, Q., & Wang, B. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04537-5 · Cited by 2
He, D., Sun, J., BHAWAL, U. K., Fukuoka, C. Y., Huang, Y.-C., Hamada, N., & Arakawa, H. (2014) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.23.55 · Cited by 2
Heme oxygenase-1 gene delivery for altering high mobility group box-1 protein in pancreatic islet
Kim, M. J., Hwang, Y. H., Hwang, J. W., Alam, Z., & Lee, D. Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.031 · Cited by 2
Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis
Holmannová, D., Císařová, B., Borský, P., Fiala, Z., Andrýs, C., Hamáková, K., Švadláková, T., Krejsek, J., Palička, V., Kotingová, L., et al. (2021) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2022.3 · Cited by 2
Polly Matzinger's “danger model” finds its predicted danger-denoting self moieties
Palazón, A., Dubrot, J., Martínez‐Forero, I., Rouzaut, A., Ochoa, C., Perez‐Gracia, J. L., Hervás‐Stubbs, S., & Melero, I. (2008) · Inmunología · doi:10.1016/s0213-9626(08)70068-4 · Cited by 2
HMGB1: un lien entre inflammation septique et non septique
Barnay‐Verdier, S., Maréchal, V., & Borde, C. (2009) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(09)70310-7 · Cited by 2
Tang, K., Hsieh, T., Chen, Y., Hsieh, C.-W., Chen, Y., & Chen, D.-Y. (2014) · Lupus · doi:10.1177/0961203314530791 · Cited by 2
Roles for Infections in Systemic Lupus Erythematosus Pathogenesis
Vista, E. S., Farris, A. D., & James, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10024-5 · Cited by 2
Translational Nephrology: Taking Aim at Tubular Debris
Lindquist, J. A., & Mertens, P. R. (2016) · Journal of Clinical & Experimental Nephrology · doi:10.21767/2472-5056.100012 · Cited by 2
Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)
Land, W. (2018) · Damage-Associated Molecular Patterns in Human Diseases · doi:10.1007/978-3-319-78655-1_12 · Cited by 2
Sancar, S., Torkay, G., & Çan, T. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10540-3 · Cited by 2
Oxidative Stress-Induced Molecular and Genetic Mechanisms in Human Health and Diseases
Dholia, N., Ramteke, P., Varghese, J. F., Rani, V., & Yadav, U. C. S. (2014) · Springer eBooks · doi:10.1007/978-81-322-2035-0_7 · Cited by 2
Phagocytes and Immunoglobulins
Martínez‐Pomares, L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00005-4 · Cited by 2
Wang, J., Zhu, J., Mao, D. H., Zhu, S., Mi, X. G., & Yu, Q. (2019) · Neoplasma · doi:10.4149/neo_2019_190221n147 · Cited by 2
Apte, R. N., & Voronov, E. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_8 · Cited by 1
Neuroinflammation in the Genesis of Epilepsy
Rani, R., Paliwal, S., & Nain, S. (2025) · Current Psychopharmacologye · doi:10.2174/0122115560347296250211081124 · Cited by 1
Scola, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1404161 · Cited by 1
Racanati, A., Tribout, T., Sabuj, A. A. M., Blanc, F., Cuyabano, B. C. D., Lecoeur, A., Brard‐Fudulea, S., Bruneau, N., Gourichon, D., Bécot, L., et al. (2025) · animal · doi:10.1016/j.animal.2025.101686 · Cited by 1
The Role of Short-Chain Fatty Acids Produced by Oral Bacteria in Modulating Oral Immunity
Tsuda, H., & Mikami, Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03176-1_4 · Cited by 1
Proton beam therapy induces protective immunity via HMGB1-dependent signaling
Wen, J., Tu, X., Ren, W., Wang, Q., Wang, Y., Guo, G., Osada, K., Shimokawa, T., Akihisa, T., Nakajima, N. I., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1686678 · Cited by 1
Wei, A., Zhang, Y., 许禹, Schneider, J., Detterman, N., Shu, X., Gregersen, T., Folch, M. N., Li, Y., Chen, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093853 · Cited by 1
Caffeic Acid and Its Derivatives as Potential Therapies for Neurological Disorders
Nasrullah, M. Z. (2026) · Current Neuropharmacology · doi:10.2174/011570159x433688260331181025 · Cited by 1
Feldmann, M., & Monaco, C. G. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_18 · Cited by 1
Iosif, C., Jianu, M. E., Sarafoleanu, C., Duda, R., Panaitescu, E., & Davila, C. (2013) · Cited by 1
Cross-talk between bone marrow mesenchymal stem cells and injured tissue
Tamai, K. (2016) · Annals of Japan Prosthodontic Society · doi:10.2186/ajps.8.342 · Cited by 1
Liu, H., Zhao, Q., Song, Q., Zhou, F.-H., Kang, H.-J., Pan, L., & Ym, Y. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200110 · Cited by 1
Myeloid-derived Suppressor Cells in Cancer: A Review on the Pathogenesis and Therapeutic Potentials
Richard, S. A. (2018) · The Open Cancer Immunology Journal · doi:10.2174/1876401001807010016 · Cited by 1
Febriza, A., & Idrus, H. H. (2024) · The Open Biochemistry Journal · doi:10.2174/011874091x277312231123093133 · Cited by 1
Hill, G. R., Yang, J., Easton, L. E., Cerdan, R., McLaughlin, S. H., Stott, K. M., TRAVERS, A. A., & Neuhaus, D. (2024) · ChemBioChem · doi:10.1002/cbic.202400395 · Cited by 1
Gene Therapy for Cognitive Recovering After Ischemic Stroke
Vargas, J. A. G., Posada‐Duque, R., & Cardona‐Gómez, G. P. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_13 · Cited by 1
Cell Death and Autoimmune Disease
Gallucci, S., Caricchio, R., & Cohen, P. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00016-6 · Cited by 1
Montivero, A., Ghersi, M., Catalan, J., Formica, M. L., Camacho, N., Culasso, A. F., Hereñú, C. B., Palma, S. D., & Pérez, M. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_20 · Cited by 1
Recent Advances in Scar Biology
Ogawa, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-399-7 · Cited by 1
Andersson, U. (2022) · Medical Research Archives · doi:10.18103/mra.v10i5.2783 · Cited by 1
Neuroprotection by erythropoietin
Cervellini, I. (2012) · University of Brighton Repository (University of Brighton) · Cited by 1
[Diagnosis of dementia--an objective examination or a subjective evaluation?].
Tybjerg, J., & Sørensen, L. U. (1994) · PubMed · Cited by 1
Berge, G. M. (2009) · NORA - Norwegian Open Research Archives · Cited by 1
Role of HMGB1 in Periodontal Disease
Ebe, N., Hara‐Yokoyama, M., & Izumi, Y. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4614-9557-4_11
The role of the cytokines IL-17A and IL-33 in inflammatory arthritis and psoriasis
Hueber, A. J. (2011) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.2629
Coppola, A. (2009) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.58015/coppola-andrea_phd2009-11-03
Reversing Breast Cancer-Induced Immune Suppression
Beury, D. W., & Ostrand‐Rosenberg, S. (2013) · doi:10.21236/ada573503
SYNTHESIS AND CHARACTERIZATION OF POLYMERIC ANTIOXIDANT DELIVERY SYSTEMS
Wattamwar, P. P. (2011) · UKnowledge (University of Kentucky)
Berrocal Almanza, L. C. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-11018
Dendritic cell responses to apoptotic cells : Is there life after death?
Johansson, U. (2010) · Figshare
Gallucci, S., Caricchio, R., & Cohen, P. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00017-4
Becker, K. J., & Hallenbeck, J. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8915-3_16
Coordinated Regulation of MAPK and STAT3 Proteins on TNF-α Transcription Activity*
Li-Ping, Y. A. N. G., Yao, Y.-M., Li, J., Ye, Q., & Sheng, Z. (2009) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2008.00552
Owusu, L., Wang, B., Du, Y., Li, W., & Xin, Y. (2015) · Journal of Cancer · doi:10.7150/jca.10787
Research Highlight Ancient News: HMGBs are Universal Sentinels
Bianchi, M. E., & Celona, B. (2015)
Self-citationAmoudruz, P. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
HMGB1 in inflammation - secretion and function
Wähämaa, H. (2008) · Figshare
The Role Of Inflammation In A New Rabbit Model Of Post-Traumatic Osteoarthritis
Huebner, K. D. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28326
The influence of gut-derived bacteria on systemic adaptive immune responses
Bonn, R. F.-W.-U., & Schwandt, T. (2010) · bonndoc (University of Bonn)
Crawford, C. L., Zong, W., Sabino, G. J., Furie, M. B., Kew, R. R., Guerriero, L., Ditsworth, D., & Catanzaro, J. M. (2011)
Thrombomodulin-Protein-C-System und Protein Z
Vinnikov, I. A., Nawroth, P. P., & Isermann, B. (2010) · Springer eBooks · doi:10.1007/978-3-642-01544-1_26
Mechanisms mediating macrophage activation during acetaminophen-induced hepatotoxicity
Dragomir, A.-C. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3xw4hm7
Inflammation and epilepsy: the contribution of astrocytes
Zurolo, E. (2013) · UvA-DARE (University of Amsterdam)
Regulation of Innate Immune Responses by Nucleic Acid Analogues
Yanai, H. (2011) · Uirusu · doi:10.2222/jsv.61.141
Experimental and clinical findings of HMGB1 in sepsis and inflammation
Okamoto, K., Nagato, M., Tamura, T., Higure, A., & Yamaguchi, K. (2010) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.21.619
Drosophila immune responses in a model for epithelial hypertrophy
Krautz, R. (2016)
Modulatory actions of HMGB1 on TLR4 and rage in the primary afferent sensory neuron
Allette, Y. M. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2099
Wu, M. O. (2015) · TSpace (University of Toronto)
Platelet activation in trauma and other inflammatory conditions
Montague, S. J. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Helminth-Derived Immunomodulatory
Adisakwattana, M., & Saunders, S. P. (2009)
Vargas, J. A. G., & Cardona‐Gómez, G. P. (2017) · Revista de la Academia Colombiana de Ciencias Exactas Físicas y Naturales · doi:10.18257/raccefyn.437
Molecular Mechanisms of Immunogenic Cell Death
Musella, M., Manic, G., Vitale, I., & Sistigu, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.12294-0
HMGB1 INDUCES TENDINOPATHY DEVELOPMENT DUE TO MECHANICAL OVERLOADING
Zhang, J., Zhao, G., Li, F., & Hc, J. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Jyoti, F. (2013) · NDSU Repository (North Dakota State University)
Serratos, I. N., López-Macay, Á., Castellanos, P., Córdoba-Herrera, J. G., Pérez‐Montfort, R., Cabrera, N., Arechavaleta-Velasco, F., Domínguez-López, P., & Santamarı́a, A. (2019) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v63i1.574
Étude des mécanismes d'action de la PhotoChimiothérapie Extra-corporelle chez l'Homme
Hannani, D. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Development and clinical application of regeneration-inducing HMGB1 peptide drug
Tamai, K. (2021) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.32.289
Manfredi, A. A., Campana, L., & Cottone, L. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13370988.14741094
Self-citation(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816983-4.00003-1
Neuroimmunologic aspects of febrile status epilepticus
Gallentine, W. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00017-2
Muhammad, A. K. M. G., Candolfi, M., King, G. D., Yagiz, K., Foulad, D. S., Mineharu, Y., Kroeger, K. M., Treuer, K. A., Nichols, W. S., Sanderson, N., et al. (2023) · doi:10.1158/1078-0432.c.6517752
Grothe, L. M. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9849
Gök, S., Okyar, B., Tuncel, D. A., Tolun, F. İ., Baylan, F. A., Acıpayam, C., Doğaner, A., & Çetin, G. Y. (2024) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1287352
Aβ-HMGB1 complex is a pathogenic molecule at the advanced stage of Alzheimer’s diseasePreprint
Tanaka, H., Homma, H., Yoshioka, Y., Fujita, K., Yamada, S., Furukawa, K., Ishiki, A., Atsuta, N., Waragai, M., Mano, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.659430
Platform for drug discovery targeting HMGB1, AGEs-RAGE response
Mori, S., Takahashi, H. K., & Toyomura, T. (2014) · Folia Pharmacologica Japonica · doi:10.1254/fpj.143.14
Wang, X., Bu, H.-F., Zhong, W., Asai, A., Zhou, Z., & Tan, X.-D. (2013) · Figshare · doi:10.6084/m9.figshare.7194260
Chen, W.-T., Wei, J.-F., Wang, L., Zhang, D., Tang, W., Wang, J., Yong, Y., Wang, J., Zhou, Y.-L., Yuan, L., et al. (2019) · Figshare · doi:10.6084/m9.figshare.11479632
Rovere, G., Matas, Y. C., Vidal‐Villegas, B., Bernal-Garro, J. M., Sobrado‐Calvo, P., Salinas-Navarro, M., Nucci, C., Villegas‐Pérez, M. P., Vidal‐Sanz, M., Agudo‐Barriuso, M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031502
Yapici, T., Menteşe, B., Pekmezci, M. Y., Yapıcı, N. A., Kutlu, N., Mete, M., Uluer, E. T., & Ozbilgin, M. K. (2026) · Biotechnic & Histochemistry · doi:10.1080/10520295.2026.2645058
Dialogue entre le complément C1 et l'alarmine HMGB1 dans l'inflammation
Lorvellec, M. (2024) · theses.fr (ABES) · doi:10.70675/0098aa7azc426z4ad1zb78czeee46320fdb2
Dissanayake, W. M. N., Gamage, M. A. G. N. D. M. A., Lee, S.-M., & Yi, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9540379/v1
A systemic nanozyme therapeutic disrupts the ROS-inflammation circuit to prevent multi-organ injury
Huang, Y., Liu, Y., Wu, R., Yan, H., Li, Z., Zheng, Y., Cai, X., & Chen, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.180116
Fang, D., Cielecka‐Piontek, J., Blundell, R. A., Zhong, Z., & Chen, J. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158707
Immunogenic cell death in CNS diseases: From bench to bedside
Li, P., Zhou, Z., Qing, Y., Wei, X., Mei, Z., & Zhang, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103342
Soh, Q. R., Pefanis, A., Baghani‐Aval, H., Ezhilarasu, J., Furtado, R. V., Skene, A., Corcoran, D., Trajceska, L., Sunil, K., Vilayil, A. J., et al. (2026) · ANZ Journal of Surgery · doi:10.1111/ans.71031
HMGB1, RAGE, and the Myeloid Response to Pancreatic Cancer
Vernon, P. J. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Regulated necrosis in kidney ischemia-reperfusion injury
Pefanis, A., Ierino, F. L., Murphy, J. M., & Cowan, P. J. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.009 · Cited by 361
Metadata
- Authors
- Bianchi, M. E., & Manfredi, A. A.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Bianchi, Marco E.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2007-10-30
- Volume
- 220
- Issue
- 1
- Pages
- 35-46
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2109590683
- Cited by
- 600
- References
- 86
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 28 · 2021: 21 · 2020: 17 · 2019: 25 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 37 · 2014: 44 · 2013: 55 · 2012: 45
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- HMGB1, high mobility group box 1, innate immunity, adaptive immunity, inflammation, tissue repair, dendritic cell maturation, T cell activation, autoimmunity, necrosis, chemokines, stem cell recruitment, autocrine and paracrine signaling
- MeSH terms
- Animals, Dendritic Cells, Humans, Immunity, Innate, Lupus Erythematosus, Systemic, T-Lymphocytes, Autoimmunity, Sepsis, HMGB1 Protein, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review